Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
The Urologic Clinics of North America
|
November 24, 2022
Progress and Promise of Biomarker Discovery and Development in Urologic Disease
Adam S Feldman
Oncology (Williston Park, N.Y.)
|
June 18, 2016
POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
Adam S Feldman
Urologic Oncology
|
April 30, 2021
Seminars Issue - COVID-19 and its impact on urologic oncology - Introduction to the first issue in a two-part series
Adam S Feldman
The Journal of Urology
|
August 25, 2011
Long-term outcome of excisional organ sparing surgery for carcinoma of the penis
Adam S Feldman, W Scott McDougal
Current Opinion in Pediatrics
|
April 8, 2006
Diagnosis and management of dysfunctional voiding
Adam S Feldman, Stuart B Bauer
Expert Review of Anticancer Therapy
|
November 30, 2010
Advances in the evaluation and management of lymph node involvement in urothelial carcinoma of the bladder
Mohummad Minhaj Siddiqui, Adam S Feldman
Cancer Biomarkers : Section a of Disease Markers
|
May 6, 2009
Nanoparticle imaging for genitourinary cancers
Brian H Eisner, Adam S Feldman
Urologic Oncology
|
July 28, 2021
A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers
Adam S Feldman, Vinata Lokeshwar, Daniel W Lin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2018
Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation
Alejandro Sanchez, Adam S Feldman, A Ari Hakimi
Urologic Oncology
|
January 15, 2008
The potential of nanoparticle-enhanced imaging
Adam S Feldman, W Scott McDougal, Mukesh G Harisinghani
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
The Urologic Clinics of North America
|
November 24, 2022
Progress and Promise of Biomarker Discovery and Development in Urologic Disease
Adam S Feldman
Oncology (Williston Park, N.Y.)
|
June 18, 2016
POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
Adam S Feldman
Urologic Oncology
|
April 30, 2021
Seminars Issue - COVID-19 and its impact on urologic oncology - Introduction to the first issue in a two-part series
Adam S Feldman
The Journal of Urology
|
August 25, 2011
Long-term outcome of excisional organ sparing surgery for carcinoma of the penis
Adam S Feldman, W Scott McDougal
Current Opinion in Pediatrics
|
April 8, 2006
Diagnosis and management of dysfunctional voiding
Adam S Feldman, Stuart B Bauer
Expert Review of Anticancer Therapy
|
November 30, 2010
Advances in the evaluation and management of lymph node involvement in urothelial carcinoma of the bladder
Mohummad Minhaj Siddiqui, Adam S Feldman
Cancer Biomarkers : Section a of Disease Markers
|
May 6, 2009
Nanoparticle imaging for genitourinary cancers
Brian H Eisner, Adam S Feldman
Urologic Oncology
|
July 28, 2021
A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers
Adam S Feldman, Vinata Lokeshwar, Daniel W Lin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2018
Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation
Alejandro Sanchez, Adam S Feldman, A Ari Hakimi
Urologic Oncology
|
January 15, 2008
The potential of nanoparticle-enhanced imaging
Adam S Feldman, W Scott McDougal, Mukesh G Harisinghani
Page
of 11